University of Wisconsin
School of Medicine and Public Health

Ravi Dhingra, MD, MPH



MADISON, WI 53792-0001

(608) 263-0080

Dr. Ravi Dhingra joined the Department of Medicine in the Division of Cardiovascular Medicine as an Assistant Professor in September 2013. Dr. Dhingra received his medical schooling from Armed Forces Medical College in Pune, India. After completing his internship and residency in India Dr. Dhingra came to United States where he completed his Internal Medicine training from Brookdale University Hospital in Brooklyn, NY. Thereafter, he joined the NHLBI's Framingham Heart Study for cardiovascular epidemiology research fellowship. Dr. Dhingra also received further training in Preventive Cardiology from Brigham and Women's Hospital VA Boston Healthcare, and was appointed Chief Preventive Cardiology Fellow. After his training, he stayed as a Clinical Instructor of Medicine at Harvard Medical School. Dr. Dhingra also attended the Harvard School of Public Health and received his Masters in Public Health. Dr. Dhingra received his clinical cardiology training from Dartmouth Hitchcock Medical Center in Lebanon, NH. Dr. Dhingra received his Advanced Heart failure and Heart Transplant training from Tufts Medical Center in Boston, MA. Dr. Dhingra is currently board certified in internal medicine, cardiovascular medicine, echocardiography, advanced heart failure and transplant cardiology.

Dr. Dhingra's research focuses on epidemiology of heart Failure and cardiovascular diseases. His specific research interests are in studying the metabolic and nutritional biomarkers in relation to cardiovascular diseases including heart failure and ventricular remodeling. He has published several first-authored research articles in peer-reviewed journals. One of his research articles on Soft drink Consumption and the Risk of Metabolic Syndrome received wide recognition and was bestowed the ‘best article of the year' award in 2007 from the American Heart Association, Circulation editorial board.

His clinical interests includes assessment of heart failure risk and prognosis, treatment of hypertrophic cardiomyopathy, advanced heart failure management with use of mechanical circulatory support devices and heart transplantation.